RIPK3 has been found to modulate the lipid metabolic reprogramming of tumor-associated macrophages, thereby regulating the immunometabolism 27 and facilitating immune evasion 28 in hepatocellular carcinoma (HCC). Here, RIPK3 is linked to neoplasm.